Clinical Trial Update: The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two furosemide strategies in patients with cardiorenal syndrome; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorenal Syndrome

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Hospital Civil de Guadalajara | Conditions: Cardiorenal Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2020-09-14